Investigation by Parkinson’s Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson’s disease: further results of randomised trial and confidential inquiry

Objective: To determine whether the excess mortality observed in patients who received both levodopa and selegiline in a randomised trial could be explained by revised diagnosis of Parkinson’s disease, autonomic or cardiovascular effects, more rapid disease progression, or drug interactions. Design:...

ver descrição completa

Detalhes bibliográficos

Publicado no:	BMJ
Principais autores:	Ben-Shlomo, Y, Churchyard, A, Head, J, Hurwitz, B, Overstall, P, Ockelford, J, Lees, A J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1998
Assuntos:	Papers
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC28519/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9583926/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.316.7139.1191
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!